In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii

Acinetobacter baumannii is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-kill an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antibiotics (Basel)
Main Authors: Abdul-Mutakabbir, Jacinda C., Yim, Juwon, Nguyen, Logan, Maassen, Philip T., Stamper, Kyle, Shiekh, Zain, Kebriaei, Razieh, Shields, Ryan K., Castanheira, Mariana, Kaye, Keith S., Rybak, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300792/
https://ncbi.nlm.nih.gov/pubmed/34356801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10070880
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados